RBC Capital Upgrades BioCryst Pharma (BCRX) to Outperform, 'Doc Survey Suggesting Good Orladeyo Metrics'
Tweet Send to a Friend
(Updated - September 18, 2023 6:18 AM EDT)
RBC Capital analyst Brian Abraham upgraded BioCryst Pharma (NASDAQ: BCRX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Brian Abraham upgraded BioCryst Pharma (NASDAQ: BCRX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
